Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease

Variables Overall n = 293 WL < 5 % n = 205 WL = 5–6.99 % n = 34 WL = 7–9.99 % n = 25 WL ≥ 10 % n = 29 P value** Weight loss (%) 3.8 ± 2.7 1.78 ± 0.16 5.86 ± 0.09 8.16 ± 0.22 13.04 ± 6.6 – Resolution of steatohepatitisa 72…

read more

Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation

Energy 25–40 kcal/kg/day, with extra 10 % in patients with ascites Carbohydrate • 50–60 % of total calories • Blood glucose monitoring recommended especially in patients treated with corticosteroids Protein…

read more

Hepatic and Extrahepatic Malignancies in NAFLD

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Hepatic and Extrahepatic Malignancies in NAFLD

Author, year [ref.] Country/setting/period Study design/cohort definition/control group Number of patients/follow-up HCC incidence in cohort vs. control group HCC mortality in cohort vs. control group Sorensen et al., 1998 [57]…

read more

Animal Models of Nonalcoholic Fatty Liver Disease

Oct 6, 2016 by in GASTROENTEROLOGY Comments Off on Animal Models of Nonalcoholic Fatty Liver Disease

Model Description Advantages Limitations Methionine-choline-deficient diet (MCD) •High-sucrose (40 %) and high-fat (10–20 %) diet lacking methionine and choline •Impaired VLDL assembly and β-oxidation of fatty acids •Day 10: NASH…

read more
Get Clinical Tree app for offline access